Literature DB >> 9852984

Cytokine production in varicella-zoster virus-stimulated cultures of human blood lymphocytes.

A R Hayward1, M Cosyns, M Jones, M J Levin, E Villanueba, A Weinberg, C Y Chan.   

Abstract

Estimates of responder cell frequency (RCF) based on limiting dilution analyses are laborious, and alternative means to quantitate cell-mediated immunity to immunogens are desirable. It was shown that levels of interleukin (IL)-2 in the supernatant of varicella-zoster virus-stimulated blood lymphocytes from immune adults peaked at 48 h of culture and correlated partially with estimates of RCF (r = .74, P = .003). Levels of gamma-interferon, IL-4, and IL-10 increased through the first 4 days of culture, and gamma-interferon levels showed some correlation with peak IL-2 levels (r = .48, P = .03). Nevertheless, correlations between levels of these cytokines and RCF did not reach statistically significant levels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852984     DOI: 10.1086/514266

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  4 in total

Review 1.  Neonatal innate immunity to infectious agents.

Authors:  László Maródi
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

2.  Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.

Authors:  J G Smith; X Liu; R M Kaufhold; J Clair; M J Caulfield
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

3.  Local immune responses and systemic cytokine responses in zoster: relationship to the development of postherpetic neuralgia.

Authors:  M Zak-Prelich; R C McKenzie; A Sysa-Jedrzejowska; M Norval
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

4.  Evaluation of Chosen Cytokine Levels among Patients with Herpes Zoster as Ability to Provide Immune Response.

Authors:  Agata Zajkowska; Adam Garkowski; Renata Świerzbińska; Alina Kułakowska; Monika Emilia Król; Iwona Ptaszyńska-Sarosiek; Anna Nowicka-Ciełuszecka; Sławomir Pancewicz; Piotr Czupryna; Anna Moniuszko; Joanna Zajkowska
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.